GSK3B and diabetes mellitus: In the DM + CI group, phosphorylation of GSK-3β was decreased from day 0 to month 3 compared to the control group (P < 0.05, P < 0.01, P < 0.01, P < 0.01, P < 0.01, P < 0.01).